Internal Medicine, Hematology & Oncology · Saint Louis, MO
NPI
1023088564
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
607 S New Ballas Rd, Suite 3300
Saint Louis, MO, 63141
Phone (314) 251-4986
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
2,187 services
Medicare patients, 2024
603
Average age 74
Drug cost, 2024
$12.1M
3,964 prescriptions
Company payments, 2025
$2,360
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John W Finnie was code 99213 (office e&m - established), 885 times for 448 patients. In total John W Finnie billed 2,187 services in 14 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 885 | 448 | $47.10 | $42K |
| 99213 Office E&M - Established | Office | 348 | 276 | $42.94 | $15K |
| 99214 Office E&M - Established | Facility | 299 | 113 | $69.56 | $21K |
| 99232 Hospital E&M - Subsequent | Facility | 219 | 76 | $59.16 | $13K |
| 99214 Office E&M - Established | Office | 218 | 104 | $73.26 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 46 | 29 | $90.14 | $4,146 |
| 99205 Office E&M - New | Facility | 33 | 33 | $133.28 | $4,398 |
| 99204 Office E&M - New | Facility | 32 | 32 | $99.50 | $3,184 |
| 99223 Hospital E&M - Initial | Facility | 21 | 20 | $131.86 | $2,769 |
| 99215 Office E&M - Established | Facility | 18 | 16 | $94.08 | $1,693 |
| 99205 Office E&M - New | Office | 17 | 17 | $122.80 | $2,088 |
| 99231 Hospital E&M - Subsequent | Facility | 16 | 11 | $37.76 | $604 |
| 99204 Office E&M - New | Office | 13 | 13 | $71.23 | $926 |
By year: 2022 $202K for 2,558 services; 2023 $193K for 2,418 services; 2024 $128K for 2,187 services.
Medicare prescription drug claims, 2024
In 2024, the drug John W Finnie prescribed most often to Medicare patients was Eliquis (Apixaban), with 268 prescriptions and refills. In total John W Finnie wrote 3,964 Medicare prescriptions that cost $12.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 268 | 456 | 52 | $261K |
| Xtandi Enzalutamide | 261 | 261 | 34 | $3.3M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 213 | 213 | 51 | $5,202 |
| Anastrozole Generic | 211 | 503 | 53 | $2,220 |
| Levothyroxine Sodium Generic | 144 | 314 | 29 | $922 |
| Methylphenidate Hcl Generic | 124 | 124 | 29 | $2,518 |
| Prednisone Generic | 115 | 138 | 24 | $578 |
| Folic Acid Generic | 112 | 237 | 26 | $843 |
| Hydroxyurea Generic | 108 | 199 | 21 | $1,165 |
| Pantoprazole Sodium Generic | 92 | 165 | 25 | $628 |
| Xarelto Rivaroxaban | 88 | 178 | 23 | $97K |
| Alprazolam Generic | 80 | 88 | 15 | $252 |
| Dexamethasone Generic | 80 | 110 | 26 | $1,040 |
| Lorazepam Generic | 78 | 78 | 26 | $240 |
| Oxycodone Hcl Generic | 76 | 76 | 21 | $1,573 |
Brand drugs: - claims; generic drugs: 2,688 claims; opioid claims: 395.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John W Finnie $2,360 ($2,360 in general payments such as food, travel and fees) from 31 companies. The largest payer was Daiichi Sankyo Inc. with $338.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 17 | $338 |
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $258 |
| EMD Serono, Inc. MRK.DE | 16 | $211 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $176 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $141 |
| Gilead Sciences, Inc. GILD | 6 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $90.06 |
| Celgene Corporation BMY | 6 | $86.44 |
| Abbvie Inc. ABBV | 3 | $83.96 |
| Pfizer Inc. PFE | 7 | $83.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.